T1	Participants 392 416	28 maternal-infant pairs
T2	Participants 208 239	185 Pharmacokinetic Study Group
T3	Participants 114 160	HIV-infected pregnant women and their newborns
T4	Participants 1225 1271	HIV-infected pregnant women and their newborns
